Deflazacort Oral Suspension
Product Images NDC 70377-188

14 FDA label images from Biocon Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Deflazacort Oral Suspension (NDC 70377-188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figurea (Figure001)

Figurea (Figure001)
An instructional illustration showing the components included with Deflazacort oral suspension: a suspension bottle, a bottle adapter, an oral dispenser, and a household cup with spoon, alongside the product carton. This image depicts the intended tools for dosing and administering the suspension orally.*
FDA Label Image

Figureb (Figure002)

Figureb (Figure002)
An instructional illustration showing a hand holding a bottle with arrows and motion lines indicating the bottle should be shaken well. The image is likely intended as a preparation step for an oral suspension medication.*
FDA Label Image

Figurec (Figure003)

Figurec (Figure003)
An instructional illustration showing a hand pressing down on a child-resistant cap of a bottle, indicating how to open or secure the cap of a medication bottle.*
FDA Label Image

Figured (Figure004)

Figured (Figure004)
An instructional diagram showing hands pressing down on a bottle adapter using both thumbs. The ribbed end of the adapter is labeled, demonstrating how to properly apply pressure to open or secure the bottle.*
FDA Label Image

Figurei (Figure009)

Figurei (Figure009)
An instructional illustration showing a hand holding a syringe dispensing liquid into a small cup, with an arrow indicating downward movement. A spoon is placed next to the cup, suggesting medication administration guidance.*
FDA Label Image

Figurej (Figure010)

Figurej (Figure010)
An instructional illustration showing a hand stirring the contents of a cup with a spoon. The hand is gripping the spoon, and an arrow indicates a circular stirring motion inside the cup.*
FDA Label Image

Figurek (Figure011)

Figurek (Figure011)
An instructional illustration showing a hand twisting to open the cap of a bottle, likely demonstrating how to open the packaging of Deflazacort Oral Suspension.*
FDA Label Image

Figurel (Figure012)

Figurel (Figure012)
An instructional illustration showing a hand holding a syringe by the barrel with the thumb on the plunger. An upward arrow indicates pushing the plunger upwards. Labels identify the plunger and barrel parts of the syringe.*
FDA Label Image

Figuree (Figure05)

Figuree (Figure05)
An instructional diagram of an oral dosing syringe for Deflazacort Oral Suspension showing labeled parts: plunger and barrel. The syringe has volume markings to measure liquid medication accurately.*
FDA Label Image

Figuref (Figure06)

Figuref (Figure06)
An instructional diagram showing a hand holding a syringe with a plunger positioned above an open bottle, indicating the action of inserting the syringe into the bottle for oral suspension withdrawal.*
FDA Label Image

Figureg (Figure07)

Figureg (Figure07)
An instructional diagram showing how to measure a dose with a syringe from the widest part of the plunger. The syringe is positioned below an inverted bottle, demonstrating proper dose measurement technique.*
FDA Label Image

Figureh (Figure08)

Figureh (Figure08)
Instructional line drawing showing a hand holding a measuring syringe being inserted and twisted into the neck of a bottle, with an arrow indicating upward motion to withdraw liquid. This depicts how to use the syringe to measure and withdraw oral suspension from the bottle.*
FDA Label Image

Carton (Image01)

Carton (Image01)
Packaging label for Deflazacort Oral Suspension 22.75 mg/mL in a 13 mL bottle by Biocon Pharma Inc. The label includes dosage form as oral suspension for oral administration, with storage instructions and content details. The label also shows manufacturer information, a barcode, and the NDC 70377-188-21.*
FDA Label Image

Tris Chemdraw Structure (Structure01)

Tris Chemdraw Structure (Structure01)
Chemical structure diagram of deflazacort, showing its molecular framework with labeled atoms and bonds in a steroid-like arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.